Publisher： Adis International
ISSN： 0114-9954
Source： Reactions Weekly, Vol.1, Iss.1252, 2009-01, pp. : 6-6
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Adalimumab/etanercept/infliximab: Skin disorders: 11 case reports
Reactions Weekly, Vol. 1, Iss. 1163, 2007-01 ,pp. :
Access to resources
Recommend
Adalimumab/etanercept/infliximab: Neurological disorders: 10 case reports
Reactions Weekly, Vol. 1, Iss. 1388, 2012-01 ,pp. :
Adalimumab/etanercept/infliximab: Neurological disorders: 9 case reports
Reactions Weekly, Vol. 1, Iss. 1400, 2012-01 ,pp. :
Adalimumab/etanercept/infliximab: Endophthalmitis leading to vision loss: 3 case reports
Reactions Weekly, Vol. 1, Iss. 1210, 2008-01 ,pp. :
Adalimumab/etanercept/infliximab: Drug-induced lupus erythematosus: 3 case reports
Reactions Weekly, Vol. 1, Iss. 1207, 2008-01 ,pp. :